Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fabien Rollot

Showing results (41-50 of 50) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 50 results.
JAMA Neurology|August 4, 2025
Therapeutic Management During Pregnancy and Relapse Risk in Women With Multiple SclerosisAntoine Gavoille, Fabien Rollot, Romain Casey, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|September 4, 2025
Target trial emulation to replicate randomised clinical trials using registry data in multiple sclerosisAntoine Gavoille, Mikail Nourredine, Fabien Rollot, et al.
European Journal of Neurology|May 2, 2025
Secondary progression activity monitoring in MS despite an early highly active treatment the SPAM studyMikael Cohen, Fabien Rollot, Marc Debouverie, et al.
Neurology|July 14, 2019
Comparative effectiveness of teriflunomide vs dimethyl fumarate in multiple sclerosisDavid-Axel Laplaud, Romain Casey, Laetitia Barbin, et al.
Neurology|December 23, 2022
Investigating the Long-term Effect of Pregnancy on the Course of Multiple Sclerosis Using Causal InferenceAntoine Gavoille, Fabien Rollot, Romain Casey, et al.
Neurology|July 16, 2025
Use of Disease-Modifying Therapies in Patients With Late-Onset Multiple SclerosisCamille Robin, Fabien Rollot, Mathilde Lefort, et al.
Brain : a Journal of Neurology|February 14, 2026
Progression independent of relapse and MRI activity and treatment strategies in multiple sclerosisFabien Rollot, Romain Casey, Anne Kerbrat, et al.
JAMA Neurology|July 1, 2024
Acute Clinical Events Identified as Relapses With Stable Magnetic Resonance Imaging in Multiple SclerosisAntoine Gavoille, Fabien Rollot, Romain Casey, et al.
JAMA Neurology|March 25, 2024
High-Efficacy Therapy Discontinuation vs Continuation in Patients 50 Years and Older With Nonactive MSGuillaume Jouvenot, Guilhem Courbon, Mathilde Lefort, et al.
Neurology|May 5, 2026
Differences in Use of Disease-Modifying Therapies Between Patients With Late-Onset and Adult-Onset Relapsing-Remitting Multiple SclerosisAntoine Gavoille, Anne Kerbrat, Gilles Edan, et al.
Pageof 5

Showing results (41-50 of 50) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 50 results.
JAMA Neurology|August 4, 2025
Therapeutic Management During Pregnancy and Relapse Risk in Women With Multiple SclerosisAntoine Gavoille, Fabien Rollot, Romain Casey, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|September 4, 2025
Target trial emulation to replicate randomised clinical trials using registry data in multiple sclerosisAntoine Gavoille, Mikail Nourredine, Fabien Rollot, et al.
European Journal of Neurology|May 2, 2025
Secondary progression activity monitoring in MS despite an early highly active treatment the SPAM studyMikael Cohen, Fabien Rollot, Marc Debouverie, et al.
Neurology|July 14, 2019
Comparative effectiveness of teriflunomide vs dimethyl fumarate in multiple sclerosisDavid-Axel Laplaud, Romain Casey, Laetitia Barbin, et al.
Neurology|December 23, 2022
Investigating the Long-term Effect of Pregnancy on the Course of Multiple Sclerosis Using Causal InferenceAntoine Gavoille, Fabien Rollot, Romain Casey, et al.
Neurology|July 16, 2025
Use of Disease-Modifying Therapies in Patients With Late-Onset Multiple SclerosisCamille Robin, Fabien Rollot, Mathilde Lefort, et al.
Brain : a Journal of Neurology|February 14, 2026
Progression independent of relapse and MRI activity and treatment strategies in multiple sclerosisFabien Rollot, Romain Casey, Anne Kerbrat, et al.
JAMA Neurology|July 1, 2024
Acute Clinical Events Identified as Relapses With Stable Magnetic Resonance Imaging in Multiple SclerosisAntoine Gavoille, Fabien Rollot, Romain Casey, et al.
JAMA Neurology|March 25, 2024
High-Efficacy Therapy Discontinuation vs Continuation in Patients 50 Years and Older With Nonactive MSGuillaume Jouvenot, Guilhem Courbon, Mathilde Lefort, et al.
Neurology|May 5, 2026
Differences in Use of Disease-Modifying Therapies Between Patients With Late-Onset and Adult-Onset Relapsing-Remitting Multiple SclerosisAntoine Gavoille, Anne Kerbrat, Gilles Edan, et al.
Pageof 5